Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FZN81
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,678.70 to DMS Pharmaceutical Group Inc. for Nucala 100 mg/ml auto-injector medication, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order was issued under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
This delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, supporting the Defense Logistics Agency's Medical Supply Chain division with diverse pharmaceutical products ranging from specialty biologics to routine medications. The company's performance on numerous prior delivery orders and its $499.9 billion ceiling-value IDC, which extends through December 31, 2036, position it as a key regional prime vendor contractor capable of fulfilling the specialized pharmaceutical requirements of military medical operations globally.
Quick answers
Who was awarded contract SPE2DB26FZN81?
SPE2DB26FZN81 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FZN81 worth?
The government has obligated $5,679 on SPE2DB26FZN81.
Is contract SPE2DB26FZN81 an order under another contract?
Yes. SPE2DB26FZN81 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB26FZN81 competed?
The extent of competition for SPE2DB26FZN81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award